scispace - formally typeset
Open AccessJournal ArticleDOI

Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.

Douglas J. Christie, +2 more
- 01 Jan 1985 - 
- Vol. 75, Iss: 1, pp 310-314
Reads0
Chats0
TLDR
Findings suggest that binding of drug-induced antibodies to platelets occurs at the Fab domains of the IgG molecule.
Abstract
Platelets coated with quinine- or quinidine-induced antibodies form rosettes around protein A-Sepharose beads and normal platelets form rosettes about protein A-Sepharose beads coated with these antibodies. These reactions occurred only in the presence of sensitizing drug. Platelets also formed rosettes about protein A-Sepharose beads coated with an anti-PIA1 antibody, but drug was not required. Formation of rosettes between antibody-coated platelets and protein A-Sepharose was inhibited by F(ab')2 fragments of goat antibody specific for the Fc portion of human IgG, while rosette formation between antibody-coated protein A-Sepharose and platelets was inhibited by F(ab')2 fragments directed against the F(ab')2 portion of the IgG molecule. Since binding of IgG to protein A is known to occur via the Fc region, these findings suggest that binding of drug-induced antibodies to platelets occurs at the Fab domains of the IgG molecule.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Cefotetan-induced immunologic thrombocytopenia.

TL;DR: Failure of the antibody to react with drug-coated platelets suggests the possibility that, in this patient, sensitization to cefotetan involved mechanisms other than formation of typical hapten-carrier complexes normally described for members of the cephalosporin family of antibiotics.
Book ChapterDOI

Adverse drug reactions affecting blood cells.

TL;DR: This chapter discusses idiosyncratic drug reactions affecting blood and blood forming tissues with an emphasis on those thought to be immune-mediated, as would be expected since cellular immune effector cells have little direct access to circulating blood cells.
Journal ArticleDOI

Quinine-mediated disseminated intravascular coagulation

TL;DR: A 79-year-old woman, who was previously fit and healthy, was admitted via Accident and Emergency with a recent onset of multiple bruises, melaena, and hypotension, which occurred after only two doses of quinine sulphate separated by an interval of 3 months.
Book ChapterDOI

CHAPTER 49 – Drug-Induced Thrombocytopenia

TL;DR: HIT is a common and sometimes serious side effect of this widely used anticoagulant, and the clinical presentation and pathogenesis of HIT is complex and unique and is discussed separately in Chapter 48.
Journal ArticleDOI

Drug-mediated thrombocytopenia.

TL;DR: Thrombocytopenia due to drug-dependent antibodies most frequently occurs with quinine/quinidine and with heparin and the mode of action of these antibodies and the nature of their antigenic determinants remain unclear.
References
More filters
Journal ArticleDOI

A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies

TL;DR: It is concluded that, in PNH, platelets and granulocytes share the membrane defect characteristic of erythrocytes in this disorder, and these observations support the concept that PNH arises as the result of a somatic mutation in a primitive cell capable of differentiating into ery Throttleblast, myeloblast, and megakaryoblast lines.
Journal ArticleDOI

Allergic purpura, including purpura due to foods, drugs and infections.

TL;DR: Purpura occurring during convalescence can best be explained on the assumption of an allergic basis, similar perhaps to that to which nephritis following streptococcal infections has been attributed.
Journal ArticleDOI

Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.

TL;DR: Results of this study were consistent with the possibilities that the protein moiety of a haptenic antigen involved in development of an antibody which attaches to a cell is not necessarily a component of the cell, and that the cell reacts with the antibody by virtue of having a surface favorable for non-specific adsorption of certain haptene-antibody complexes.
Journal ArticleDOI

Cyclic AMP metabolism in cholesterol-rich platelets.

TL;DR: It is demonstrated that incorporation of cholesterol into platelet membranes is associated with a diminished inhibitory effect of prostaglandin E, on platelet aggregation and therefore adenosine 3’:5’-monophosphate production in these platelets.
Journal ArticleDOI

Drug-Antibody-Platelet Interaction in Quinine- and Quinidine-induced Thrombocytopenia

TL;DR: It is demonstrated that in quinine- and quinidine-induced thrombocytopenia, drug and antibody combine first in the soluble phase to form a complex, which then binds with high affinity to a receptor on the platelet surface (innocent bystander reaction), and that these antibodies are heterogeneous in respect to the amount of drug required to promote their binding to platelets, the number of platelet receptors they recognize, and their binding affinities.
Related Papers (5)